TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Octapharma AS
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
147,557
|
429,019
|
437,963 |
| Financial expenses |
1
|
4
|
0 |
| Earnings before taxes |
6,140
|
13,950
|
15,791 |
| Total assets |
39,768
|
129,112
|
146,520 |
| Current assets |
39,556
|
129,027
|
146,438 |
| Current liabilities |
11,491
|
50,625
|
78,913 |
| Equity capital |
28,277
|
78,487
|
67,607 |
| - share capital |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
71.1%
|
60.8%
|
46.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
4.2%
|
3.3%
|
3.6% |
| Return on assets (ROA) |
15.4%
|
10.8%
|
10.8% |
| Current ratio |
344.2%
|
254.9%
|
185.6% |
| Return on equity (ROE) |
21.7%
|
17.8%
|
23.4% |
| Change turnover |
-281,462
|
-8,944
|
83,844 |
| Change turnover % |
-66%
|
-2%
|
24% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.